BR0111601A - Método para o tratamento de doença cardiovascular - Google Patents
Método para o tratamento de doença cardiovascularInfo
- Publication number
- BR0111601A BR0111601A BR0111601-0A BR0111601A BR0111601A BR 0111601 A BR0111601 A BR 0111601A BR 0111601 A BR0111601 A BR 0111601A BR 0111601 A BR0111601 A BR 0111601A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- cardiovascular disease
- mammal
- cardiovascular
- disease
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 abstract 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 abstract 1
- 229960002930 sirolimus Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"MéTODO PARA O TRATAMENTO DE DOENçA CARDIOVASCULAR". A invenção refere-se a um método para o tratamento ou a inibição de doença cardiovascular, vascular cerebral, ou vascular periférica em um mamífero que necessite do referido tratamento, que compreende proporcionar ao referido mamífero uma quantidade eficaz de uma rapamicina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21211700P | 2000-06-16 | 2000-06-16 | |
PCT/US2001/019179 WO2001097809A2 (en) | 2000-06-16 | 2001-06-14 | Method of treating cardiovascular disease using rapamycin |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0111601A true BR0111601A (pt) | 2003-07-01 |
Family
ID=22789625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0111601-0A BR0111601A (pt) | 2000-06-16 | 2001-06-14 | Método para o tratamento de doença cardiovascular |
Country Status (19)
Country | Link |
---|---|
US (1) | US20020013335A1 (pt) |
EP (1) | EP1292302A2 (pt) |
JP (1) | JP2003535899A (pt) |
KR (1) | KR20030010710A (pt) |
CN (1) | CN1436076A (pt) |
AR (1) | AR028959A1 (pt) |
AU (2) | AU2001268446B2 (pt) |
BR (1) | BR0111601A (pt) |
CA (1) | CA2412636A1 (pt) |
CZ (1) | CZ20024115A3 (pt) |
EA (1) | EA200300027A1 (pt) |
HU (1) | HUP0301244A3 (pt) |
IL (1) | IL153405A0 (pt) |
MX (1) | MXPA02012410A (pt) |
NO (1) | NO20026008D0 (pt) |
NZ (1) | NZ523114A (pt) |
PL (1) | PL365455A1 (pt) |
WO (1) | WO2001097809A2 (pt) |
ZA (1) | ZA200300418B (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ307637B6 (cs) | 2001-02-19 | 2019-01-23 | Novartis Ag | 40-O-(2-Hydroxyethyl)rapamycin jako jediná účinná látka při léčení |
US20040137066A1 (en) * | 2001-11-26 | 2004-07-15 | Swaminathan Jayaraman | Rationally designed therapeutic intravascular implant coating |
US6641611B2 (en) | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
EP1478648B1 (en) | 2002-02-01 | 2014-04-30 | ARIAD Pharmaceuticals, Inc. | Phosphorus-containing compounds and uses thereof |
US20030176455A1 (en) * | 2002-03-13 | 2003-09-18 | Wyeth | Method of inhibiting cell death |
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
ATE413163T1 (de) * | 2002-09-17 | 2008-11-15 | Wyeth Corp | Granulierte formulierung des rapamycinesters ccl- 779 |
WO2004060283A2 (en) | 2002-12-16 | 2004-07-22 | Nitromed, Inc. | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
AR042938A1 (es) | 2003-02-06 | 2005-07-06 | Wyeth Corp | Uso del cci-779 en el tratamiento de la fibrosis hepatica |
US7728033B2 (en) | 2003-05-05 | 2010-06-01 | Clinigene International Private Limited | Mycophenolate mofetil in diabetic nephropathy |
US7220755B2 (en) | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
DE102004019845A1 (de) * | 2004-03-29 | 2005-10-20 | Krka Tovarna Zdravil D D | Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung |
US20050232965A1 (en) * | 2004-04-15 | 2005-10-20 | Robert Falotico | Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
EP1750862B1 (en) * | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
CN100435755C (zh) * | 2004-07-27 | 2008-11-26 | 微创医疗器械(上海)有限公司 | 药物洗脱支架 |
EP1656941A1 (en) * | 2004-11-09 | 2006-05-17 | Clinigene International Private Limited | Compositions for the treatment of diabetic nephropathy |
GB0503936D0 (en) | 2005-02-25 | 2005-04-06 | San Raffaele Centro Fond | Method |
CN100384416C (zh) * | 2006-03-20 | 2008-04-30 | 杨军 | 一种用于治疗心血管疾病的药物组合物 |
US20080175887A1 (en) * | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
WO2015103447A1 (en) | 2013-12-31 | 2015-07-09 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
EP2547642B1 (en) | 2010-03-15 | 2016-01-13 | ExxonMobil Chemical Patents Inc. | Processes for the production of alcohols |
WO2014059295A1 (en) * | 2012-10-12 | 2014-04-17 | The Board Of Regents Of The University Of Texas System | Use of mtor inhibitors to treat vascular cognitive impairment |
US10098871B2 (en) * | 2013-03-15 | 2018-10-16 | Leslie B. Gordon | Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
CN105997940A (zh) * | 2016-05-11 | 2016-10-12 | 中国人民解放军第三军医大学 | 炎症微环境响应性纳米药物、其制备方法及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
US5373014A (en) * | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
GB9606452D0 (en) * | 1996-03-27 | 1996-06-05 | Sandoz Ltd | Organic compounds |
ATE283687T1 (de) * | 1997-06-13 | 2004-12-15 | Wyeth Corp | Rapamycin-formulierungen zur oralen verabreichung |
US6015809A (en) * | 1998-08-17 | 2000-01-18 | American Home Products Corporation | Photocyclized rapamycin |
-
2001
- 2001-06-13 US US09/880,295 patent/US20020013335A1/en not_active Abandoned
- 2001-06-14 JP JP2002503293A patent/JP2003535899A/ja active Pending
- 2001-06-14 AU AU2001268446A patent/AU2001268446B2/en not_active Ceased
- 2001-06-14 WO PCT/US2001/019179 patent/WO2001097809A2/en not_active Application Discontinuation
- 2001-06-14 CA CA002412636A patent/CA2412636A1/en not_active Abandoned
- 2001-06-14 BR BR0111601-0A patent/BR0111601A/pt not_active IP Right Cessation
- 2001-06-14 PL PL01365455A patent/PL365455A1/xx not_active Application Discontinuation
- 2001-06-14 EA EA200300027A patent/EA200300027A1/ru unknown
- 2001-06-14 NZ NZ523114A patent/NZ523114A/en unknown
- 2001-06-14 EP EP01946387A patent/EP1292302A2/en not_active Ceased
- 2001-06-14 HU HU0301244A patent/HUP0301244A3/hu unknown
- 2001-06-14 CZ CZ20024115A patent/CZ20024115A3/cs unknown
- 2001-06-14 IL IL15340501A patent/IL153405A0/xx unknown
- 2001-06-14 MX MXPA02012410A patent/MXPA02012410A/es not_active Application Discontinuation
- 2001-06-14 CN CN01811212A patent/CN1436076A/zh active Pending
- 2001-06-14 KR KR1020027017036A patent/KR20030010710A/ko not_active Application Discontinuation
- 2001-06-14 AU AU6844601A patent/AU6844601A/xx active Pending
- 2001-06-15 AR ARP010102877A patent/AR028959A1/es not_active Application Discontinuation
-
2002
- 2002-12-13 NO NO20026008A patent/NO20026008D0/no not_active Application Discontinuation
-
2003
- 2003-01-15 ZA ZA200300418A patent/ZA200300418B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1292302A2 (en) | 2003-03-19 |
PL365455A1 (en) | 2005-01-10 |
AR028959A1 (es) | 2003-05-28 |
US20020013335A1 (en) | 2002-01-31 |
JP2003535899A (ja) | 2003-12-02 |
IL153405A0 (en) | 2003-07-06 |
AU6844601A (en) | 2002-01-02 |
NO20026008L (no) | 2002-12-13 |
CN1436076A (zh) | 2003-08-13 |
ZA200300418B (en) | 2004-04-15 |
AU2001268446B2 (en) | 2005-08-11 |
MXPA02012410A (es) | 2003-04-25 |
HUP0301244A2 (hu) | 2003-08-28 |
WO2001097809A3 (en) | 2002-05-10 |
CA2412636A1 (en) | 2001-12-27 |
WO2001097809A2 (en) | 2001-12-27 |
CZ20024115A3 (cs) | 2003-06-18 |
KR20030010710A (ko) | 2003-02-05 |
HUP0301244A3 (en) | 2005-01-28 |
EA200300027A1 (ru) | 2003-06-26 |
NZ523114A (en) | 2004-07-30 |
NO20026008D0 (no) | 2002-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0111601A (pt) | Método para o tratamento de doença cardiovascular | |
BR0016652A (pt) | Métodos para inibir angiopatia amilóide cerebral, para tratar um estado de doença caracterizado por angiopatia amilóide cerebral em um indivìduo, e para diagnosticar angiopatia amilóide cerebral em um indivìduo | |
CY1119109T1 (el) | Συσκευη που μπορει να εμφυτευθει που περιεχει υλικο μητρας που μπορει να απορροφηθει και ραπαμυκινη για την προληψη ή την θεραπεια αγγειο-πολλαπλασιαστικων ασθενειων | |
BR0206644A (pt) | Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares | |
BR0206639A (pt) | Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares | |
BR0215168A (pt) | Métodos para retardar a senescência e tratamento e prevenção de doenças associadas com senescência | |
BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
PT1318837E (pt) | Metodo de tratamenton de carcinoma positivo a receptor de estrogenio | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
WO2005039504A3 (en) | Compounds and methods for treating toll-like receptor 2-related diseases and conditions | |
BRPI0307673A2 (pt) | métodos de tratar doença vascular. | |
ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
PT1052905E (pt) | Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol | |
ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
BRPI0408491A (pt) | tratamento da doença de alzheimer | |
WO2002039994A3 (en) | Methods for the treatment and prevention of urinary stone disease | |
MA27503A1 (fr) | Composition et methode de traitement du diabete. | |
BRPI0417108A (pt) | métodos de tratamento de rejeições de transplantes em pacientes | |
EP1254260A4 (en) | METHODS FOR DIAGNOSING AND TREATING A HEART DISEASE | |
DK0888330T3 (da) | Fremgangsmåder til behandling eller forebyggelse af interstitiel cystitis | |
BR0115882A (pt) | Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária | |
FR2781504B1 (fr) | Foulon pour le traitement des cuirs, peaux et similaires | |
WO2002062205A3 (en) | Methods for diagnosing and treating heart disease | |
ITRM990707A0 (it) | Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni | |
WO2001010384A3 (en) | Method for identifying compounds for treatment of insulin resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |